Suchergebnisse - "Yokoyama, Keitaro"

PubPharm (200)

1

Hepcidin/Ferritin Ratios Differ Among Non-Dialyzed Chronic Kidney Disease Patients, and Patients on Hemodialysis and Peritoneal Dialysis

enthalten in: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy | 2019

von Niikura, T. | Maruyama, Y. | Nakashima, S. | +6

2

Randomised clinical trial of ferric citrate hydrate on anaemia management in haemodialysis patients with hyperphosphataemia : ASTRIO study

enthalten in: Scientific reports | 2019

von Yokoyama, K. | Fukagawa, M. | Akiba, T. | +5

3

Long-Term Efficacy and Safety of Evocalcet in Japanese Patients with Secondary Hyperparathyroidism Receiving Hemodialysis

enthalten in: Scientific reports | 2019

von Yokoyama, K. | Shimazaki, R. | Fukagawa, M. | +17

4

Evaluation of changes in ferritin levels during sucroferric oxyhydroxide treatment

enthalten in: Clinical kidney journal | 2019

von Koiwa, F. | Yokoyama, K. | Fukagawa, M. | +1

5

Clinical outcome of incident peritoneal dialysis patients with diabetic kidney disease

enthalten in: Clinical and experimental nephrology | 2019

von Kishida, K. | Maruyama, Y. | Asari, K. | +7

6

Effect of bixalomer on coronary artery calcification in hemodialysis patients with hyperphosphatemia: a multi-center, randomized controlled trial

enthalten in: Renal replacement therapy | 2019

von Akiba, T. | Yokoyama, K. | Hase, H. | +5

7

Effect of diabetes on incidence of peritoneal dialysis-associated peritonitis

enthalten in: PloS one | 2019

von Ueda, R. | Nakao, M. | Maruyama, Y. | +9

8

Hepcidin/Ferritin Ratios Differ Among Non‐Dialyzed Chronic Kidney Disease Patients, and Patients on Hemodialysis and Peritoneal Dialysis

enthalten in: Therapeutic Apheresis and Dialysis | 2019

von Niikura, T. | Maruyama, Y. | Nakashima, S. | +6

9

Effect of Oral Alfacalcidol on Clinical Outcomes in Patients Without Secondary Hyperparathyroidism Receiving Maintenance Hemodialysis : The J-DAVID Randomized Clinical Trial

enthalten in: JAMA | 2018

von J-DAVID Investigators | Shoji, T. | Inaba, M. | +59

CommentIn: JAMA. 2018 Dec 11;320(22):2319-2321. - PMID 30535205

10

Effects of the Intravenous Calcimimetic Etelcalcetide on Bone Turnover and Serum Fibroblast Growth Factor 23 : Post Hoc Analysis of an Open-label Study

enthalten in: Clinical therapeutics | 2018

von Shigematsu, T. | Fukagawa, M. | Yokoyama, K. | +4

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[20]